human-human hybridoma technology was used to immortalize human b lymphocytes from patients with acute myeloid leukemia ( aml ) to study the antigenic repertoire of the humoral immune response against the patients ' own leukemia cells and against leukemic cells from other patients .
C0023467
acute myeloid leukemia
C1517806
leukemic cells